144 related articles for article (PubMed ID: 3174761)
1. Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats.
Weiss F; Tanzer DJ; Ettenberg A
Pharmacol Biochem Behav; 1988 Jun; 30(2):309-17. PubMed ID: 3174761
[TBL] [Abstract][Full Text] [Related]
2. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
Crawley JH
Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
[TBL] [Abstract][Full Text] [Related]
3. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
Weiss F; Ettenberg A; Koob GF
Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
[TBL] [Abstract][Full Text] [Related]
4. Enkephalin prevents CCK-induced enhancement of amphetamine-induced locomotor stereotypy.
Mueller K; Whiteside DA
Brain Res; 1990 Apr; 513(1):119-24. PubMed ID: 2350675
[TBL] [Abstract][Full Text] [Related]
5. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
Crawley JN; Hommer DW; Skirboll LR
Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
[TBL] [Abstract][Full Text] [Related]
6. Influence of cholecystokinin on central monoaminergic pathways.
Widerlöv E; Kalivas PW; Lewis MH; Prange AJ; Breese GR
Regul Pept; 1983 May; 6(2):99-109. PubMed ID: 6308717
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats.
Tieppo CA; Silva AM; Palermo-Neto J; Nasello AG; Felicio LF
Braz J Med Biol Res; 1995 Mar; 28(3):351-4. PubMed ID: 8520531
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence.
Crawley JN; Stivers JA; Blumstein LK; Paul SM
J Neurosci; 1985 Aug; 5(8):1972-83. PubMed ID: 4040554
[TBL] [Abstract][Full Text] [Related]
9. Infusions of cholecystokinin octapeptide into the ventral tegmental area potentiate amphetamine conditioned place preferences.
Pettit HO; Mueller K
Psychopharmacology (Berl); 1989; 99(3):423-6. PubMed ID: 2594910
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
Kihara T; Ikeda M; Matsubara K; Matsushita A
Eur J Pharmacol; 1993 Jan; 230(3):271-7. PubMed ID: 8440305
[TBL] [Abstract][Full Text] [Related]
11. Specificity of nucleus accumbens to activities related to cholecystokinins in rats.
Katsuura G; Itoh S; Hsiao S
Peptides; 1985; 6(1):91-6. PubMed ID: 3991366
[TBL] [Abstract][Full Text] [Related]
12. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
Van Ree JM; Gaffori O; De Wied D
Eur J Pharmacol; 1983 Sep; 93(1-2):63-78. PubMed ID: 6138272
[TBL] [Abstract][Full Text] [Related]
13. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
[TBL] [Abstract][Full Text] [Related]
14. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
Katsuura G; Hsiao S; Itoh S
Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
[TBL] [Abstract][Full Text] [Related]
15. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
Vaccarino FJ; Rankin J
Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
[TBL] [Abstract][Full Text] [Related]
16. The relationship between stereotypy and memory improvement produced by amphetamine.
Carr GD; White NM
Psychopharmacology (Berl); 1984; 82(3):203-9. PubMed ID: 6425900
[TBL] [Abstract][Full Text] [Related]
17. Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens.
Kolta MG; Shreve P; Uretsky NJ
Neuropharmacology; 1989 Jan; 28(1):9-14. PubMed ID: 2927583
[TBL] [Abstract][Full Text] [Related]
18. Reversed behavioral effect of cholecystokinin after frontal decortication in rats.
Itoh S; Katsuura G; Itoh T; Morimoto T
Life Sci; 1994; 55(11):PL213-6. PubMed ID: 8072383
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation.
Conti LH; Segal DS; Kuczenski R
Psychopharmacology (Berl); 1997 Mar; 130(2):183-8. PubMed ID: 9106917
[TBL] [Abstract][Full Text] [Related]
20. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
